Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Amyloidosis Research Consortium.  Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Needs Statement

The main clinical gaps to be addressed by the class are:

  • Clinicians need to better understand the presentation of amyloidosis symptoms and how to identify and diagnose possible amyloidosis patients.
  • Clinicians need to know what steps to take once they have identified a possible amyloidosis patient and who, how and when to refer.
  • Clinicians need to have current knowledge of treatments and the impact on progression of disease and survival.
  • Clinicians need to understand the important role of multidisciplinary teams in caring for patients with amyloidosis



Following this activity, participants will be able to:

  1. Identify signs, symptoms and features that should raise suspicion for a potential diagnosis of amyloidosis.
  2. Outline the methods available for testing for amyloidosis including possible limitations of specific tests.
  3. Discuss data from recent clinical trials outlining possible treatment and potential patients who would benefit.
  4. Identify challenges and possible barriers to treatment, including disease severity, financial burden, and potential outcomes.
  5. Apply clinical algorithms to case studies.
  6. Recognize best practices for a multidisciplinary approach to amyloidosis clinical care.


Target Audience

This conference is designed for a broad audience of clinicians involved in the care and treatment of patients with amyloidosis. The collective target audience will include General Cardiologists, Nuclear Cardiologists, Neurologists, Hematologists, Heart Failure Specialists, Heart Failure Nurses, and Echocardiographers.


Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Boston University are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.